Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKFT
3801
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $484K | ﹤0.01% |
11,900
-11,900
| -50% | -$438K |
|
3802
CALL
Denali Therapeutics
DNLI
$3.97B
| $483K | ﹤0.01% |
+22,500
| New | +$446K |
|
|
3803
PUT
Denali Therapeutics
DNLI
$3.97B
| $483K | ﹤0.01% |
+22,500
| New | +$446K |
|
|
IMA
3804
ImageneBio Inc
IMA
$64.6M
| $482K | ﹤0.01% |
20,388
+3,176
| +18% | +$104K |
|
3805
MediaAlpha
MAX
$821M
| $481K | ﹤0.01% |
43,169
+27,536
| +176% | +$273K |
|
3806
Prime Medicine
PRME
$559M
| $481K | ﹤0.01% |
54,235
-10,905
| -17% | -$84K |
|
3807
CVRx
CVRX
$63.4M
| $480K | ﹤0.01% |
15,279
+13,317
| +679% | +$250K |
|
3808
Entrada Therapeutics
TRDA
$267M
| $479K | ﹤0.01% |
31,730
+25,798
| +435% | +$382K |
|
3809
Esquire Financial Holdings
ESQ
$1.14B
| $477K | ﹤0.01% |
9,555
+8,372
| +708% | +$393K |
|
3810
Axogen
AXGN
$2.5B
| $477K | ﹤0.01% |
69,877
+41,222
| +144% | +$229K |
|
3811
Lantronix
LTRX
$266M
| $477K | ﹤0.01% |
81,437
+41,687
| +105% | +$210K |
|
3812
Avita Medical
RCEL
$240M
| $473K | ﹤0.01% |
34,480
+30,143
| +695% | +$346K |
|
3813
Orange County Bancorp
OBT
$518M
| $473K | ﹤0.01% |
15,706
+12,146
| +341% | +$291K |
|
|
GRP.U
3814
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $472K | ﹤0.01% |
8,186
+211
| +3% | +$10.9K |
|
3815
West Bancorporation
WTBA
$485M
| $472K | ﹤0.01% |
22,248
+19,603
| +741% | +$350K |
|
|
FSP
3816
Franklin Street Properties
FSP
$46.8M
| $471K | ﹤0.01% |
183,845
+123,707
| +206% | +$267K |
|
3817
Black Diamond Therapeutics
BDTX
$112M
| $470K | ﹤0.01% |
167,246
-155,000
| -48% | -$364K |
|
3818
NewtekOne
NEWT
$391M
| $468K | ﹤0.01% |
33,928
+29,880
| +738% | +$418K |
|
3819
CALL
Builders FirstSource
BLDR
$8.04B
| $467K | ﹤0.01% |
2,800
-104,000
| -97% | -$13.8M |
|
|
RSVR
3820
Reservoir Media
RSVR
$667M
| $466K | ﹤0.01% |
65,362
+23,083
| +55% | +$141K |
|
3821
Carter Bankshares
CARE
$731M
| $465K | ﹤0.01% |
31,039
+27,092
| +686% | +$341K |
|
3822
Accuray
ARAY
$34M
| $463K | ﹤0.01% |
163,685
+117,516
| +255% | +$321K |
|
3823
PUT
Riot Platforms
RIOT
$7.76B
| $463K | ﹤0.01% |
29,900
| – | – |
|
3824
iShares Biotechnology ETF
IBB
$9.77B
| $461K | ﹤0.01% |
3,397
-16,383
| -83% | -$2M |
|
3825
Westrock Coffee
WEST
$803M
| $461K | ﹤0.01% |
45,194
+36,617
| +427% | +$328K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.